Important pharmacophores for binding to galanin receptor 2LUNDSTRÖM, Linda; XIAOYING LU; LANGEL, Ülo et al.Neuropeptides (Edinburgh). 2005, Vol 39, Num 3, pp 169-171, issn 0143-4179, 3 p.Conference Paper

Galnon : a low-molecular weight ligand of the galanin receptorsSOLLENBERG, Ulla; BARTFAI, Tamas; LANGEL, Ülo et al.Neuropeptides (Edinburgh). 2005, Vol 39, Num 3, pp 161-163, issn 0143-4179, 3 p.Conference Paper

Galanin and galanin receptors in human cancersBERGER, Alexandra; SANTIC, Radmila; HAUSER-KRONBERGER, Cornelia et al.Neuropeptides (Edinburgh). 2005, Vol 39, Num 3, pp 353-359, issn 0143-4179, 7 p.Conference Paper

Homodimerization and internalization of galanin type 1 receptor in living CHO cellsWIRZ, Sebastian A; DAVIS, Christopher N; XIAOYING LU et al.Neuropeptides (Edinburgh). 2005, Vol 39, Num 6, pp 535-546, issn 0143-4179, 12 p.Article

Galanin receptor ligandsXIAOYING LU; LUNDSTRÖM, Linda; LANGEL, Ulo et al.Neuropeptides (Edinburgh). 2005, Vol 39, Num 3, pp 143-146, issn 0143-4179, 4 p.Conference Paper

Analysis of the contribution of galanin receptors 1 and 2 to the central actions of galanin-like peptideKRASNOW, Stephanie M; HOHMANN, John G; GRAGEROV, Alexander et al.Neuroendocrinology (Basel). 2004, Vol 79, Num 5, pp 268-277, issn 0028-3835, 10 p.Article

The galanin peptide family in inflammationLANG, Roland; KOFLER, Barbara.Neuropeptides (Edinburgh). 2011, Vol 45, Num 1, pp 1-8, issn 0143-4179, 8 p.Article

Anxiolytic-like activity of the non-selective galanin receptor agonist, galnonJOHANNES, S; RAJARAO, R; BEYER, Chad E et al.Neuropeptides (Edinburgh). 2007, Vol 41, Num 5, pp 307-320, issn 0143-4179, 14 p.Article

Pharmacological and functional characterization of galanin-like peptide fragments as potent galanin receptor agonistsLANG, Roland; BERGER, Alexandra; SANTIC, Radmila et al.Neuropeptides (Edinburgh). 2005, Vol 39, Num 3, pp 179-184, issn 0143-4179, 6 p.Conference Paper

Novel galanin receptor subtype specific ligands in feeding regulationSAAR, Indrek; RUNESSON, Johan; MCNAMARA, Ilan et al.Neurochemistry international. 2011, Vol 58, Num 6, pp 714-720, issn 0197-0186, 7 p.Article

Determining receptor―ligand interaction of human galanin receptor type 3RUNESSON, Johan; SOLLENBERG, Ulla E; JURKOWSKI, Wiktor et al.Neurochemistry international. 2010, Vol 57, Num 7, pp 804-811, issn 0197-0186, 8 p.Article

Galanin inhibits the proliferation of glial olfactory ensheathing cellsXIA, Chen-Yi; YUAN, Can-Xing; YUAN, Chong-Gang et al.Neuropeptides (Edinburgh). 2005, Vol 39, Num 5, pp 453-459, issn 0143-4179, 7 p.Article

Role of galanin and galanin(1-15) on central cardiovascular controlDIAZ-CABIALE, Z; PARRADO, C; VELA, C et al.Neuropeptides (Edinburgh). 2005, Vol 39, Num 3, pp 185-190, issn 0143-4179, 6 p.Conference Paper

Galanin and alcohol dependence : Neurobehavioral researchLEWIS, M. J; RADA, P; JOHNSON, D. F et al.Neuropeptides (Edinburgh). 2005, Vol 39, Num 3, pp 317-321, issn 0143-4179, 5 p.Conference Paper

Galanin negatively modulates opiate withdrawal via galanin receptor 1HOLMES, Fiona E; ARMENAKI, Athena; IISMAA, Tiina P et al.Psychopharmacologia. 2012, Vol 220, Num 3, pp 619-625, issn 0033-3158, 7 p.Article

Antinociceptive role of galanin in the spinal cord of rats with inflammation, an involvement of opioid systemsWEI XIONG; LIAN GAO; SAPRA, Aygul et al.Regulatory peptides. 2006, Vol 132, Num 1-3, pp 85-90, issn 0167-0115, 6 p.Article

Antinociceptive effects of intracerebroventricular injection of the galanin receptor 1 agonist M 617 in ratsFU, Li-Bo; WANG, Xue-Bin; SHI JIAO et al.Neuroscience letters. 2011, Vol 491, Num 3, pp 174-176, issn 0304-3940, 3 p.Article

Differential effect of galanin on proliferation of PCI2 and BI04 cellsSHUANG CHENG; YUAN, Chong-Gang.Neuroreport (Oxford). 2007, Vol 18, Num 13, pp 1379-1383, issn 0959-4965, 5 p.Article

Characterisation of a new chimeric ligand for galanin receptors: galanin(1-13)-[D-Trp³²]-neuropeptide Y(25-36) amideSAAR, Külliki; MAHLAPUU, Riina; LAIDMÄE, Erki et al.Regulatory peptides. 2001, Vol 102, Num 1, pp 15-19, issn 0167-0115Article

Galanin receptor subtype 2 (GalR2) null mutant mice display an anxiogenic-like phenotype specific to the elevated plus-mazeBAILEY, Kathleen R; PAVLOVA, Maria N; ROHDE, Alex D et al.Pharmacology, biochemistry and behavior. 2007, Vol 86, Num 1, pp 8-20, issn 0091-3057, 13 p.Article

Galanin receptor subtypes and ligand bindingFLOREN, Anders; LAND, Tiit; LANGEL, Ülo et al.Neuropeptides (Edinburgh). 2000, Vol 34, Num 6, pp 331-337, issn 0143-4179Conference Paper

The Neuropeptide Galanin and Variants in the GaIRI Gene are Associated with Nicotine DependenceJACKSON, Kia J; XIANGNING CHEN; MILES, Michael F et al.Neuropsychopharmacology (New York, NY). 2011, Vol 36, Num 11, pp 2339-2348, issn 0893-133X, 10 p.Article

Galanin, through GalR1 but not GalR2 receptors, decreases motivation at times of high appetitive behaviorANDERSON, Maria E; RUNESSON, Johan; SAAR, Indrek et al.Behavioural brain research. 2013, Vol 239, pp 90-93, issn 0166-4328, 4 p.Article

Central administration of ghrelin preferentially enhances fat ingestionSHIMBARA, Takuya; MONDAL, Muhtashan S; KAWAGOE, Takashi et al.Neuroscience letters. 2004, Vol 369, Num 1, pp 75-79, issn 0304-3940, 5 p.Article

Galanin and galanin receptors in embryonic stem cells: accidental or essential?TARASOV, Kirill V; TARASOVA, Yelena S; CRIDER, David G et al.Neuropeptides (Edinburgh). 2002, Vol 36, Num 4, pp 239-245, issn 0143-4179, 7 p.Article